Royal Philips announced its latest introductions in analytics and interoperability solutions at the HIMSS22 Global Health Conference & Exhibition. Philips HealthSuite Interoperability is a fully integrated cloud-enabled Health IT platform to meet diverse workflow needs across the imaging enterprise. 
March 24, 2022
Philips Introduces Cloud-enabled Enterprise Imaging Informatics and Analytics Solutions at HIMSS22
March 24, 2022 — Royal Philips announced its latest introductions in analytics and interoperability solutions at the …
Read More
new research finds that people who had depression following a heart attack were about 50% more likely to suffer a stroke compared with those who didn’t have depression, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
March 24, 2022
Study: Depression After a Heart Attack Heightens Stroke Risk
March 24, 2022 – Depression can complicate and slow recovery from a heart attack, not to mention the toll it can take…
Read More
HLT Inc., a Bracco Group Company and a leader in the development of cutting edge transcatheter aortic valve replacement (TAVR) therapy, announced today that it has received U.S. Food and Drug Administration (FDA) approval for two clinical studies to assess the performance and safety of its HLT Meridian TAVR Valve System to treat aortic stenosis and aortic regurgitation among high-risk patients suffering from aortic disease.
March 24, 2022
HLT, Inc. Gains FDA Approval for Two TAVR Clinical Studies
March 24, 2022 — HLT Inc., a Bracco Group Company and a leader in the development of cutting edge transcatheter aortic…
Read More
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced today that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
March 23, 2022
FDA Recalls Quinapril Hydrochloride and Hydrochlorothiazide Tablets by Pfizer
March 23, 2022 — MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced today that Pfizer…
Read More
The dominant form of heart failure worldwide appears to be caused by a strong, bidirectional interaction between the body’s response to metabolic stress and the immune system, according to a review article written by UT Southwestern researchers and colleagues.
March 22, 2022
Dominant Form of Heart Failure Caused by Metabolic-immune Interaction, Review Article Suggests
March 22, 2022 – The dominant form of heart failure worldwide appears to be caused by a strong, bidirectional…
Read More
Risk factors for IAE
March 22, 2022
Assessing Complex Endovascular Aneurysm Repair
March 22, 2022 – A retrospective evaluation of 600 fenestrated-branched endovascular aortic repairs for the treatment…
Read More
A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the past is not associated with a recurrence of the condition or other serious side effects.
March 22, 2022
Study: COVID-19 Vaccination is Safe in Patients with Previous Myocarditis
March 22, 2022 — A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in…
Read More
A Scripps Research team developed a smartphone app that can calculate users’ genetic risk for coronary artery disease (CAD)—and found that users at high risk sought out appropriate medication after using the app.
March 22, 2022
Scripps Research Develops a Smartphone App to Calculate Genetic Risk for Heart Attack
March 22, 2022 – A Scripps Research team developed a smartphone app that can calculate users’ genetic risk for coronary…
Read More
Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC).
March 22, 2022
Women More Likely to Die After Heart Emergency than Men
March 22, 2022 –  Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to…
Read More
Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year compared to 94% of those with chest pain as the predominant feature. That’s the finding of research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC)
March 22, 2022
Shortness of Breath Heralds Worse Survival than Chest Pain for Heart Attack Patients
March 22, 2022 – Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year…
Read More
With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and endovascular care. In addition to providing quality care to tens of thousands of patients over the years, The Cardiovascular Care Group has been committed to educating the community on vascular-related conditions through the sharing of knowledge and transparency.
March 22, 2022
The Cardiovascular Care Group Raises Awareness of Peripheral Artery Disease
March 22, 2022 – With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and…
Read More
In an article published in Circulation Research, a leading cardiovascular research journal, a team of researchers at Loyola University Chicago Stritch School of Medicine identified a novel mechanism by which the heart functions, potentially leading to the discovery of a therapeutic to treat adults who experience heart failure. 
March 22, 2022
Loyola University Chicago Team Identifies a Potential Therapeutic for Heart Failure Patients
March 22, 2022 – In an article published in Circulation Research, a leading cardiovascular research journal, a team of…
Read More
Medtronic, a global leader in healthcare technology, has announced leadership transitions for three of its Operating Units – Diabetes, Surgical Robotics, and Cardiac Rhythm Management – bringing in critical skills and capabilities and creating opportunities for internal talent.
March 22, 2022
Medtronic Appoints New Operating Unit Presidents
March 22, 2022 – Medtronic, a global leader in healthcare technology, has announced leadership transitions for three of…
Read More
Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, has announced it has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its wireless Agilia Connect Infusion System which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology.
March 22, 2022
Fresenius Kabi Receives FDA 510(k) Clearance for Wireless Agilia Connect Infusion System with Vigilant Software Suite-Vigilant Master Med Technology
March 22, 2022 – Fresenius Kabi, a global health care company that specializes in medicines and technologies for…
Read More
Sumeet Chugh, MD
March 11, 2022
Cedars-Sinai Establishes New Division: Artificial Intelligence in Medicine
March 11, 2022 – The Department of Medicine at Cedars-Sinai has established a new division to explore how artificial…
Read More
Zhiqiang Lin, Ph.D., Assistant Professor at the Masonic Medical Research Institute (MMRI), along with his colleagues, are actively investigating heart disease and inflammation.
March 11, 2022
Dr. Zhiqiang Lin Awarded NIH Grant to Examine the Cardiac Innate Immune Response
March 15, 2022 – In the United States, an individual will experience a heart attack every 40 seconds. As a result of…
Read More
Vascepa
March 11, 2022
JAHA Study: Vascepa Significantly Lowered Risk of Potentially Fatal CVD Events in Patients with Prior PCI
March 15, 2022 – Amarin has announced the publication of new REDUCE-IT data analysis that helps support  the clinical…
Read More
Implicity
March 11, 2022
Implicity Hosts US Research Competition for Free Access to Advanced AI-powered Cardiac Remote Monitoring Platform
March 15, 2022 – Implicity, a leader in AI-powered remote patient monitoring and cardiac data management solutions,…
Read More
March 11, 2022
Treating Heart Attacks with a Medium Chain Fatty Acid
March 14, 2022 – A medium-chain fatty acid found in energy drinks might one day help protect against heart attack…
Read More
Rehabilitation exercises
March 11, 2022
A Virtual Way to Rehab From a Stroke
March 14, 2022 – After a stroke, patients may lose feeling in an arm or experience weakness and reduced movement that…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now